English | Español
Patient Daily | Mar 4, 2026

Radiopharmaceutical makers adjust supply chains amid fast-decaying products
Patient Daily | Mar 4, 2026

Corsera Health develops annual preventive therapy for cardiovascular disease
Patient Daily | Mar 4, 2026

Roche seeks partner for Rocephin production amid rising costs in Switzerland
Patient Daily | Mar 4, 2026

Study finds gaps in menstrual health knowledge among elite women’s footballers
Patient Daily | Mar 4, 2026

Novo Nordisk partners with Vivtex for $2.1B oral weight loss drug development
Patient Daily | Mar 4, 2026

Penn Medicine develops CRISPR tool targeting acute myeloid leukemia drivers
Patient Daily | Mar 4, 2026

New approaches emerge as industry seeks safer alternatives to opioid-based painkillers
Patient Daily | Mar 4, 2026

Sarepta CEO Doug Ingram resigns following family diagnosis

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+ Regulatory
Patient Daily | Mar 12, 2026

Texas Medical Association announces concerns over pharmacy benefit manager consolidation
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech